Viewing Study NCT06370351

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:52 PM
Ignite Modification Date: 2025-12-31 @ 8:58 PM
Study NCT ID: NCT06370351
Status: RECRUITING
Last Update Posted: 2024-09-26
First Post: 2024-04-09
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase I/II Clinical Trial with SENS-501 in Children Suffering from Severe to Profound Hearing Loss Due to Otoferlin (OTOF) Mutations
Sponsor: Sensorion
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None OTOF Gene Mutation View
None DFNB9 View
None Congenital Deafness View
None Hearing Disorders View
None Ear Diseases View
None Otorhinolaryngologic Diseases View
None Deafness View
None Hearing Loss, Sensorineural View
Keywords:

Keywords

Keyword Brief Keyword Text View
None OTOF Gene Mutation View
None Hearing impairment View
None Deafness View
None otoferlin View
None AUDIOGENE View
None Hearing Loss View
None DFNB9 View
None Hearing disorder View
None Cochlear implant View
None SENS-501 View
None Congenital Hearing loss View
None Gene therapy View